Pages that link to "Q85084971"

The following pages link to Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation (Q85084971):

Displaying 50 items.

• Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease (Q26738646) (← links)
• A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence (Q26744488) (← links)
• The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease (Q26752762) (← links)
• Endocrine causes of nonalcoholic fatty liver disease (Q26780254) (← links)
• Dietary habits and behaviors associated with nonalcoholic fatty liver disease (Q26830863) (← links)
• Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer (Q26992106) (← links)
• The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms (Q27021538) (← links)
• Vitamin D: a new player in non-alcoholic fatty liver disease? (Q28081391) (← links)
• Gut Microbiota and Host Reaction in Liver Diseases (Q28083295) (← links)
• Nutritional approaches for managing obesity-associated metabolic diseases (Q30234850) (← links)
• Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease (Q33573989) (← links)
• Vitamin D Insufficiency Exacerbates Adipose Tissue Macrophage Infiltration and Decreases AMPK/SIRT1 Activity in Obese Rats (Q33616626) (← links)
• Vitamin D3 supplementation of a high fat high sugar diet ameliorates prediabetic phenotype in female LDLR-/- and LDLR / mice. (Q33638757) (← links)
• Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients (Q33701184) (← links)
• Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease (Q33719929) (← links)
• Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease (Q33780172) (← links)
• Vitamin D and inflammatory diseases (Q33806322) (← links)
• Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity (Q33823038) (← links)
• High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes (Q34212924) (← links)
• Nonalcoholic fatty liver disease and aging: epidemiology to management. (Q34366861) (← links)
• Vitamin D deficiency in chronic liver disease. (Q34728285) (← links)
• Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis (Q34777499) (← links)
• Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults (Q35018209) (← links)
• Relation between vitamin D status and nonalcoholic fatty liver disease in children (Q35124978) (← links)
• Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease. (Q35127037) (← links)
• Can skin exposure to sunlight prevent liver inflammation? (Q35658038) (← links)
• Vitamin d deficiency in obese children and its relationship to insulin resistance and adipokines (Q35664406) (← links)
• PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE (Q35766755) (← links)
• The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controll (Q35914728) (← links)
• Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study (Q36047914) (← links)
• Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice (Q36157579) (← links)
• Theoretical basis of a beneficial role for vitamin D in viral hepatitis (Q36316676) (← links)
• 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. (Q36621631) (← links)
• The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms (Q36754953) (← links)
• The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease (Q36779181) (← links)
• Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease (Q36859567) (← links)
• Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). (Q37286751) (← links)
• Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models (Q37413503) (← links)
• Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB? (Q37715451) (← links)
• The beneficial role of vitamin D in systemic lupus erythematosus (SLE). (Q38026775) (← links)
• Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? (Q38090585) (← links)
• New insight of vitamin D in chronic liver diseases (Q38283273) (← links)
• Vitamin D modulates adipose tissue biology: possible consequences for obesity? (Q38632354) (← links)
• The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease (Q38725130) (← links)
• Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)). (Q39989268) (← links)
• Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar? (Q41766493) (← links)
• The Impact of Sex and 25(OH)D Deficiency on Metabolic Function in Mice. (Q42368235) (← links)
• Maternal vitamin D deficiency during pregnancy affects expression of adipogenic-regulating genes peroxisome proliferator-activated receptor gamma (PPARγ) and vitamin D receptor (VDR) in lean male mice offspring. (Q46475061) (← links)
• 1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2-Hemeoxygenase-1-HMGB1 Pathway in Macrophages (Q47147027) (← links)
• Effects of activated carbon N-acetylcysteine sustained-release microcapsule on dipeptidyl peptidase IV expression in young rats with non-alcoholic fatty liver disease (Q47158959) (← links)